Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes Part A: Benefits of sodium-glucose co-transporter inhibitor use in type 1 diabetes
{{output}}
There has been increasing research into non-insulin therapies to assist people living with type 1 diabetes (T1D) improve their glucose control and to help prevent the development and progression of vascular and kidney complications. In particular, the sodium-g... ...
